fontolizumab
monospecific
molnupiravir
ozogamicin
antinucleosome
antiustekinumab
anti-nuclear factor
acrixolimab
Covidly
bococizumab
coronavirus
faralimomab
ocrelizumab
atezolizumab
amlitelimab
fluorescein isothiocyanate
pan-Covid
fluorescein isocyanate
heteroclitic
kung flu
tigatuzumab
satetraxetan
COVID-positive
novid
tenatumomab
patritumab
tixagevimab
COVID-19
elsilimomab
intetumumab
immunoprobe
boomer remover
alsevalimab
sintilimab
olendalizumab
zenocutuzumab
CCP virus
sutimlimab
sasanlimab
toripalimab
Pfizer
pozelimab
vanucizumab
solitomab
cilgavimab
ziltivekimab
dinutuximab
retifanlimab
CAT